SEC Comment Letter 0000000000-23-012447 to OCULAR THERAPEUTIX, INC (OCUL) (CIK 0001393434) (OCUL)
OCULAR THERAPEUTIX, INC (OCUL) (CIK 0001393434)
Date: Nov. 13, 2023 · CIK: 0001393434 · Accession: 0000000000-23-012447
AI Filing Summary & Sentiment
File numbers found in text: 333-275373
Letter
United States securities and exchange commission logo November 13, 2023 Antony Mattessich President and Chief Executive Officer Ocular Therapeutix, Inc. 24 Crosby Drive Bedford, MA 01730 Re:Ocular Therapeutix, Inc. Registration Statement on Form S-3 Filed November 7, 2023 File No. 333-275373 Dear Antony Mattessich: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Alan Campbell at 202-551-4224 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: C.S. Avery Reaves, Esq.
Show Raw Text
United States securities and exchange commission logo
November 13, 2023
Antony Mattessich
President and Chief Executive Officer
Ocular Therapeutix, Inc.
24 Crosby Drive
Bedford, MA 01730
Re:Ocular Therapeutix, Inc.
Registration Statement on Form S-3
Filed November 7, 2023
File No. 333-275373
Dear Antony Mattessich:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Alan Campbell at 202-551-4224 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: C.S. Avery Reaves, Esq.